Get started
Author

Diane C. Young

Observed names: D C Young, D.C. Young, Diane Young
OpenAlex ID: A5108190978
Constitutive expression of the granulocyte-macrophage colony-stimulating factor gene in acute myeloblastic leukemia.
1987 · D C Young, K Wagner, et al. · Journal of Clinical Investigation · 220
PDF
Anti‐KIT monoclonal antibody CDX‐0159 induces profound and durable mast cell suppression in a healthy volunteer study
2022 · Diego Alvarado, Marcus Maurer, et al. · Allergy · 82
PDF
Intranasal seasonal influenza vaccine and a TLR-3 agonist, rintatolimod, induced cross-reactive IgA antibody formation against avian H5N1 and H7N9 influenza HA in humans
2014 · Edgar Turner Overton, Paul A. Goepfert, et al. · Vaccine · 62
Interferon‐γ induces expression of the interleukin 2 receptor gene in human monocytes
1987 · Alessandro Rambaldi, Diane C. Young, et al. · European Journal of Immunology · 53
Anti‐ KIT Barzolvolimab for Chronic Spontaneous Urticaria
2025 · Marcus Maurer, Martin Metz, et al. · Allergy · 38
PDF
Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
2020 · David R. Strayer, Diane Young, et al. · PLoS ONE · 35
PDF
RWJ-270201 (BCX-1812): a novel neuraminidase inhibitor for influenza
2001 · Diane Young, Cynthia Fowler, et al. · Philosophical Transactions of the Royal Society B Biological Sciences · 25
Imaging Androgen Receptors in Breast Cancer with 18F-Fluoro-5α-Dihydrotestosterone PET: A Pilot Study
2021 · Heather Jacene, Mofei Liu, et al. · Journal of Nuclear Medicine · 18
PDF
Successful treatment of diamond-blackfan anemia with interleukin 3
1996 · Alfred P. Gillio, Lawrence B. Faulkner, et al. · Stem Cells · 8
PDF
A phase 1 dose-escalation study of a PD-L1xCD27 bispecific antibody CDX-527 in patients with advanced malignancies.
2021 · Rachel E. Sanborn, Rodolfo Eduardo Bordoni, et al. · Journal of Clinical Oncology · 6
First stage of an on-going phase 2, open label, international, randomized, parallel design study investigating efficacy + safety of GTx-024 for advanced ER+/AR+ breast cancer (BC)
2017 · B. Overmoyer, H.S. Rugo, et al. · Annals of Oncology · 4
PDF
Phase 2 randomized study of rintatolimod following FOLFIRINOX in patients with locally advanced pancreatic adenocarcinoma.
2024 · Kelsey Klute, Vincent J. Picozzi, et al. · Journal of Clinical Oncology · 2
PDF
Mo1345: INTRAEPITHELIAL MAST CELLS ARE ELEVATED IN ACTIVE EOSINOPHILIC ESOPHAGITIS AND CORRELATE WITH EOSINOPHILS: BASELINE DATA FROM A RANDOMIZED CONTROLLED TRIAL OF BARZOLVOLIMAB
2025 · Diego Alvarado, Bradley J. Bloom, et al. · Gastroenterology · 1
Report on the PET/CT Image–Based Radiation Dosimetry of [18F]FDHT in Women, a Validated Imaging Agent with New Applications for Evaluation of Androgen Receptor Status in Women with Metastatic Breast Cancer
2023 · Keisha C. McCall, Mofei Liu, et al. · Journal of Nuclear Medicine Technology · 1
PDF
Report on the PET/CT image-based radiation dosimetry of 18FDHT in women, an imaging agent with new applications for evaluation of androgen receptor status in patients with metastatic breast cancer.
2019 · K McCall, Amanda Abbott, et al. · 1
On the Kinetics of Human Skin Mast Cell Depletion and Repopulation Following KIT Inhibition
2025 · Diego Alvarado, Deena M. Maurer, et al. · Allergy
PDF
406 CDX527–01, a phase 1 dose-escalation and expansion study of the PD-L1xCD27 bispecific antibody CDX-527 in patients with advanced malignancies
2020 · Michael Yellin, Tracey Rawls, et al. · Journal for ImmunoTherapy of Cancer
A.194 Recombinant human erythropoietin as an alternative to allogeneic transfusion In patients with mild anaemia
1996 · Richard K. Spence, Philip Faris, et al. · British Journal of Anaesthesia
Works count: 18
Citation count: 556
H-index: 8
I10-index: 8
Year
Topic
Type